Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:30 PM View:  | Day One Biopharmaceuticals,... (DAWN) | 18-Nov-24 | Option Sale | 2,602 | $13.21 | $34,372.90 | (1%) 242.74K to 240.13K | |
| 19-Nov-24 4:30 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-24 | Option Exercise | 10,250 | -- | -- | 4% 232.49K to 242.74K | |
| 17-May-24 6:15 PM View: | Day One Biopharmaceuticals,... (DAWN) | 16-May-24 | Option Sale | 2,675 | $16.08 | $43,010.50 | (1%) 227.54K to 224.87K | |
| 17-May-24 6:15 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-May-24 | Option Exercise | 10,250 | -- | -- | 5% 217.29K to 227.54K | |
| 03-May-24 6:44 PM View: | Day One Biopharmaceuticals,... (DAWN) | 03-May-24 | Sale (Planned) | 8,078 | $17.85 | $144,214.00 | (4%) 225.37K to 217.29K | |
| 03-May-24 6:44 PM View: | Day One Biopharmaceuticals,... (DAWN) | 02-May-24 | Sale (Planned) | 200 | $17.90 | $3,579.10 | (< 1%) 225.57K to 225.37K | |
| 03-May-24 6:44 PM View: | Day One Biopharmaceuticals,... (DAWN) | 01-May-24 | Private Sale (Planned) | 52,183 | $17.89 | $933,397.00 | (19%) 277.75K to 225.57K | |
| 20-Feb-24 6:36 PM View: | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-24 | Option Sale | 2,666 | $15.25 | $40,651.40 | (< 1%) 280.42K to 277.75K | |
| 20-Feb-24 6:36 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-24 | Option Exercise | 10,250 | -- | -- | 4% 270.17K to 280.42K | |
| 17-Nov-23 6:33 PM View: | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-23 | Option Sale | 956 | $11.69 | $11,175.60 | (< 1%) 271.13K to 270.17K | |
| 17-Nov-23 6:33 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-23 | Option Exercise | 3,625 | -- | -- | 1% 267.5K to 271.13K | |
| 17-Aug-23 7:02 PM View: | Day One Biopharmaceuticals,... (DAWN) | 17-Aug-23 | Option Sale | 922 | $13.86 | $12,778.90 | (< 1%) 268.42K to 267.5K | |
| 17-Aug-23 7:02 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-Aug-23 | Option Exercise | 3,625 | -- | -- | 1% 264.8K to 268.42K | |
| 17-May-23 6:36 PM View: | Day One Biopharmaceuticals,... (DAWN) | 16-May-23 | Option Sale | 955 | $13.12 | $12,531.80 | (< 1%) 265.75K to 264.8K | |
| 17-May-23 6:36 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-May-23 | Option Exercise | 3,625 | -- | -- | 1% 262.13K to 265.75K | |
| 21-Feb-23 5:01 PM View: | Day One Biopharmaceuticals,... (DAWN) | 17-Feb-23 | Private Sale (Planned) | 9,377 | $20.03 | $187,790.00 | (3%) 271.5K to 262.13K | |
| 17-Feb-23 5:35 PM View: | Day One Biopharmaceuticals,... (DAWN) | 16-Feb-23 | Option Sale | 930 | $19.57 | $18,202.90 | (< 1%) 272.44K to 271.5K | |
| 17-Feb-23 5:35 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-Feb-23 | Option Exercise | 3,625 | -- | -- | 1% 268.81K to 272.44K | |
| 23-Jan-23 6:00 PM View: | Day One Biopharmaceuticals,... (DAWN) | 20-Jan-23 | Private Sale (Planned) | 10,000 | $22.75 | $227,523.00 | (4%) 278.81K to 268.81K | |
| 22-Dec-22 5:43 PM View: | Day One Biopharmaceuticals,... (DAWN) | 20-Dec-22 | Private Sale (Planned) | 10,000 | $20.07 | $200,650.00 | (3%) 286.5K to 276.5K | |
| 22-Nov-22 6:46 PM View: | Day One Biopharmaceuticals,... (DAWN) | 21-Nov-22 | Private Sale (Planned) | 10,000 | $20.76 | $207,570.00 | (3%) 296.5K to 286.5K | |
| 17-Nov-22 5:49 PM View: | Day One Biopharmaceuticals,... (DAWN) | 16-Nov-22 | Option Sale | 430 | $21.46 | $9,227.71 | (< 1%) 296.93K to 296.5K | |
| 17-Nov-22 5:49 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-Nov-22 | Option Exercise | 1,375 | -- | -- | < 1% 294.4K to 295.78K | |
| 03-Nov-22 5:49 PM View: | Day One Biopharmaceuticals,... (DAWN) | 01-Nov-22 | Private Sale (Planned) | 10,000 | $20.03 | $200,313.00 | (3%) 304.4K to 294.4K | |
| 05-Oct-22 4:36 PM View: | Day One Biopharmaceuticals,... (DAWN) | 03-Oct-22 | Private Sale (Planned) | 10,000 | $20.05 | $200,473.00 | (3%) 314.4K to 304.4K | |
| 06-Sep-22 7:54 PM View: | Day One Biopharmaceuticals,... (DAWN) | 01-Sep-22 | Private Sale (Planned) | 10,000 | $23.25 | $232,484.00 | (3%) 324.4K to 314.4K | |
| 17-Aug-22 7:23 PM View: | Day One Biopharmaceuticals,... (DAWN) | 16-Aug-22 | Option Sale | 1,089 | $24.31 | $26,473.60 | (< 1%) 325.49K to 324.4K | |
| 17-Aug-22 7:23 PM View: | Day One Biopharmaceuticals,... (DAWN) | 15-Aug-22 | Option Exercise | 4,125 | -- | -- | 1% 321.37K to 325.49K | |
| 05-Aug-22 5:20 PM View: | Day One Biopharmaceuticals,... (DAWN) | 04-Aug-22 | Private Sale (Planned) | 10,000 | $20.05 | $200,541.00 | (3%) 331.37K to 321.37K | |
| 20-Jul-22 6:18 PM View: | Day One Biopharmaceuticals,... (DAWN) | 18-Jul-22 | Private Sale (Planned) | 2,500 | $20.00 | $50,000.00 | (< 1%) 333.87K to 331.37K | |
| 12-Jul-22 7:31 PM View: | Day One Biopharmaceuticals,... (DAWN) | 08-Jul-22 | Private Sale (Planned) | 1,416 | $20.00 | $28,320.00 | (< 1%) 335.28K to 333.87K | |
| 06-Jul-22 9:00 PM View: | Day One Biopharmaceuticals,... (DAWN) | 05-Jul-22 | Sale (Planned) | 800 | $20.00 | $16,000.00 | (< 1%) 336.08K to 335.28K | |
| 06-Jul-22 9:00 PM View: | Day One Biopharmaceuticals,... (DAWN) | 01-Jul-22 | Private Sale (Planned) | 1,479 | $20.00 | $29,580.00 | (< 1%) 337.56K to 336.08K | |
| 05-Dec-17 9:07 PM View: | Spyre Therapeutics, Inc. (SYRE) | 05-Dec-17 | Market Purchase | 10,241 | $4.76 | $48,700.10 | 42% 24.55K to 34.79K | 75% |
| 05-Dec-17 9:07 PM View: | Spyre Therapeutics, Inc. (SYRE) | 04-Dec-17 | Market Purchase | 3,259 | $4.97 | $16,196.90 | 15% 21.29K to 24.55K | 68% |
| 05-Dec-17 9:07 PM View: | Spyre Therapeutics, Inc. (SYRE) | 01-Dec-17 | Market Purchase | 6,500 | $4.59 | $29,855.20 | 44% 14.79K to 21.29K | 82% |
| 05-Dec-17 9:07 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Aug-17 | Private Purchase | 1,959 | $2.52 | $4,928.84 | 15% 12.83K to 14.79K | |
| 05-Dec-17 9:07 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Feb-17 | Private Purchase | 2,000 | $4.28 | $8,568.00 | 18% 10.83K to 12.83K | |
| 05-Dec-17 9:07 PM View: | Spyre Therapeutics, Inc. (SYRE) | 15-Aug-16 | Private Purchase | 2,000 | $3.99 | $7,974.00 | 23% 8.83K to 10.83K | |
| 12-Apr-16 5:15 PM View: | Spyre Therapeutics, Inc. (SYRE) | 12-Apr-16 | Conversion | 1,324 | -- | -- | 18% 7.5K to 8.83K | |
| 12-Apr-16 5:15 PM View: | Spyre Therapeutics, Inc. (SYRE) | 12-Apr-16 | Conversion | 11,560 | -- | -- | 131% 8.83K to 20.39K |